Prostacyclin Market Will Reach to 2580 Million US$ by 2025

This research report categorizes the global Prostacyclin market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

This report studies the global market size of Prostacyclin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Prostacyclin in these regions.Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.

The global average price of Prostacyclin is in the decreasing trend, from 60.2 USD/Unit in 2013 to 48.4 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.And in our report of prostacyclin, the "prostacyclin" means the drugs used for the treatment of pulmonary arterial hypertension.Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.

In 2017, the global Prostacyclin market size was 1760 million US$ and is forecast to 2580 million US in 2025, growing at a CAGR of 4.9% from 2018. The objectives of this study are to define, segment, and project the size of the Prostacyclin market based on company, product type, application and key regions.Prostacyclin is widely used for injection, for oral and for inhalation. The most proportion of Prostacyclin is used for oral, and the proportion in 2017 is about 55%. The trend of prostacyclin used for oral is increasing in the following years.The various contributors involved in the value chain of Prostacyclin include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Prostacyclin include

United Therapeutics

Actelion (J & J)

GSK

Teva

Toray

Tide Pharma

Bayer AG

Market Size Split by Type

Epoprostenol Sodium

Treprostinil

Iloprost

Beraprost Sodium

Market Size Split by Application

For Injection

For Oral

For Inhalation

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/737265/global-prostacyclin-market

Market size split by Region

North America

Asia-Pacific

Europe

Central & South America

Middle East & Africa

Buy Full Prostacyclin Market Report Now, Report delivery time within 24 hours
https://www.qyresearch.com/settlement/pre/a2345a5ec68c19fb460b08802c7a6566,0,1,Global%20Prostacyclin%20Market%20Insights%252C%20Forecast%20to%202025

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

This release was published on openPR.